LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,070,000 | +2.7% | 143,640 | -4.2% | 0.00% | 0.0% |
Q4 2016 | $1,042,000 | -17.8% | 149,885 | -2.7% | 0.00% | 0.0% |
Q3 2016 | $1,267,000 | +6.5% | 153,980 | +4.8% | 0.00% | 0.0% |
Q2 2016 | $1,190,000 | +59.3% | 146,954 | -0.0% | 0.00% | 0.0% |
Q1 2016 | $747,000 | -34.2% | 147,023 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,135,000 | +27.5% | 147,023 | -4.8% | 0.00% | 0.0% |
Q3 2015 | $890,000 | -27.0% | 154,517 | +16.2% | 0.00% | 0.0% |
Q2 2015 | $1,219,000 | – | 132,956 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |